Diagnos Laboratorium Utama Tbk. vs Klinko Karya Imaji Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Klinko Karya Imaji Tbk. trades at Rp97 (market cap 124.22B, 55.5K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.5× Klinko Karya Imaji Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 55.5K). Which is the better fit depends on your goals.
| DGNS | KLIN | |
|---|---|---|
Market Cap | 310.75B | 124.22B |
Volume | 963.6K | 55.5K |
Lot | 9.64K | 555 |
Turnover | 217.67M | 5.29M |
Average Price | 225.89 | 95.32 |
Value | 217.67M | 5.29M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Klinko Karya Imaji Tbk (the Company) was established on November 4, 2016 based on Notarial Deed No. 3 by Ribka Avie Alreta, S.H., M.Kn. The Company started its commercial operations in 2017.
Read more on KLIN →